Iclusig
List of products in the National Drug Code with proprietary name iclusig. Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 63020-533 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
| 63020-534 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
| 63020-535 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
| 63020-536 | Iclusig | Ponatinib Hydrochloride | Tablet, Film Coated | Oral | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |